Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
Holding NLSP?
Track your performance easily
NLSP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.73 - $20.85
Previous CloseN/A
Volume16.20M
Average Volume (3M)1.60M
Market Cap
$4.40M
Enterprise ValueN/A
Total Cash (Recent Filing)$2.18M
Total Debt (Recent Filing)$8.87M
Price to Earnings (P/E)―
Beta0.62
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding2,472,438
10 Day Avg. Volume162,788
30 Day Avg. Volume1,600,656
Standard Deviation0.27
R-Squared0.00483
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NLS Pharmaceutics News
PremiumCompany Announcements
NLS Pharmaceutics Submits Research Abstracts to ASCP 2025
PremiumCompany Announcements
NLS Pharmaceutics and Kadimastem Move Toward Merger Approval
PremiumCompany Announcements
NLS Pharmaceutics Shareholders Approve Meeting Agenda
PremiumCompany Announcements
NLS Pharmaceutics and Kadimastem Move Forward with Merger PlansOwnership Overview
―
Insiders
―
Mutual Funds
5.81% Other Institutional Investors
94.19% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
NLSP FAQ
What was NLS Pharmaceutics’s price range in the past 12 months?
NLS Pharmaceutics lowest stock price was $1.73 and its highest was $20.84 in the past 12 months.
What is NLS Pharmaceutics’s market cap?
NLS Pharmaceutics’s market cap is $4.40M.
When is NLS Pharmaceutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NLS Pharmaceutics’s earnings last quarter?
Currently, no data Available
Is NLS Pharmaceutics overvalued?
According to Wall Street analysts NLS Pharmaceutics’s price is currently Overvalued.
Does NLS Pharmaceutics pay dividends?
NLS Pharmaceutics does not currently pay dividends.
What is NLS Pharmaceutics’s EPS estimate?
NLS Pharmaceutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NLS Pharmaceutics have?
NLS Pharmaceutics has 2,472,438 shares outstanding.
What happened to NLS Pharmaceutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NLS Pharmaceutics?
Currently, no hedge funds are holding shares in NLSP
---
Company Description
NLS Pharmaceutics
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. The company focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States.
---
Technical Analysis
SAGE Therapeutics
―
Relmada Therapeutics
―
Axsome Therapeutics
―
InMed Pharmaceuticals
―
Annovis Bio
―
---